The reintroduced Humane Cosmetics Act may again face an uphill battle, despite support from both sides of the aisle, given competing administration priorities and continuing uncertainties on substantiating product safety without FDA’s acceptance of certain alternative tests.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?